A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants
PHASE1
LY2944876 is an investigative drug for the treatment of Type 2 Diabetes Mel...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)
PHASE1
This was a four-period crossover study to assess the glycemic effects of a ...
A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes Mellitus
PHASE1
The purpose of this Phase 1b study is to assess the safety and tolerability...